AIDS Therapies
Triple Combo: One Year Results
Published in AIDS Weekly, September 22nd, 1997
Fewer patients taking Crixivan progressed to AIDS defining illnesses or death than patients taking therapy without Crixivan.
An article in the September 10, 1997 issue of The New England Journal of Medicine by Roy Gulick, M.D. and colleagues at the New York University School of Medicine/Bellevue Hospital reported results from the landmark 97 patient study in which triple therapy with Merck's protease inhibitor Crixivan first suppressed HIV levels to below the limit of detection of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1997-09-22)
More Articles from AIDS Weekly
- Vector Development
Gene Delivery Effectiveness of HIV-1 Vectors Studied - AIDS Therapies
Three Drugs Better, and More Expensive, Than Two in Fighting HIV - Blood Banking (Storage)
Optimal Conditions Assure Detection of p24 Antigen - Blood Substitutes
Phase III Trials of PolyHeme Initiated - Candida albicans
Discovery of Genetic Pathways May Provide New Ways to Combat Fungal Infection - Coinfection (HIV/Mycobacterium xenopi)
Toad Parasite Causes Disease in HIV Patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
